Buprenorphine Neuraxpharm is available as multiple-strength sublingual films. The Committee for Medicinal Products for Human Use (CHMP) said its recommendation was intended to cover use in adults ...
VANCOUVER, BC / ACCESSWIRE / October 29, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to announce that it has initiated the nationalization ...
("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to announce that it has initiated the nationalization process for the filing of a family of patents for the sublingual ...
VANCOUVER, BC / ACCESSWIRE / October 29, 2024 / BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to announce that it has initiated the nationalization ...
Aquestive Therapeutics, Inc. has announced a subsequent analysis of the pivotal study of its product candidate Anaplym™ (epinephrine) sublingual film. The analysis demonstrated comparable ...
Challenges in addressing reimbursement hurdles in new markets could impact future growth. Q: Can you provide insights into the US market dynamics during Q3, particularly regarding long-acting ...